haojie Li

Dr. haojie Li

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2024 in Heliyon
Verified
Journal Article
Open access
LLLujia Li
Lujia Li
XLXiaozheng Li
Xiaozheng Li
YHYuerong Huang
Yuerong Huang
HLhaojie Li
haojie Li
CLCuihan Li
Cuihan Li
SLShaojun Lyu
Shaojun Lyu
According to statistics, about one-fifth of the world's elderly people suffer from sleep disorders, and the problem of sleep disorders in the elderly is extremely serious, and this problem is one of the important causes of chronic diseases such as hypertension, hyperlipidemia, diabetes mellitus, and coronary heart disease in the elderly. The positive effect of Tai Chi exercise therapy on sleep problems has been confirmed, but at present, the effect of the specific duration of Tai Chi exercise on the improvement of elderly people with moderate to severe sleep disorders varies. META analysis was used to investigate and find that long-term Tai Chi exercise therapy has the best effect on improving sleep in elderly patients with moderate to severe sleep disorders. Methods: META analysis was performed using Revman 5.3 after searching Web of science, Pubmed, Scopus, The Cochroae Library, OVID, CBM, CNKI, VIP, and other databases, and then filtering and extracting. A total of seven papers were included. Meta-analysis showed that tai chi exercise was more effective in improving sleep problems in elderly patients with sleep disorders compared to the control group, and the difference was significant. This was demonstrated by a decrease in the global Pittsburgh Sleep Quality Index (PSQI) score [SMD = −0.66, 95 % CI (−0.91, −0.41), P < 0.00001], as well as its subdomains of subjective sleep quality [SMD = −0.79, 95 % CI (−1.06, −0.52), P < 0.00001], sleep latency [SMD = −0.80, 95 % CI (−1.21, −0.40), P < 0.00001], sleep duration [SMD = −0.38, 95 % CI (−0.72, −0.04), P = 0.03], habitual sleep efficiency [SMD = −0.58, 95 % CI (−0.84, −0.31), P < 0.0001], sleep disturbance [SMD = −0.51, 95 % CI (−0.78, −0.25), P = 0.00001] and daytime dysfunction [SMD = −0.33, 95 % CI (−0.59, −0.07), P = 0.01]. Improvement was also observed in the Epworth Sleepiness Scale (ESS) and Insomnia Severity Index Scale (ISI). The results showed that the optimal duration and frequency of Tai Chi exercise therapy for improving moderately severe elderly patients with sleep disorders was long-term. This study systematically assessed the efficacy of Tai Chi exercise therapy for elderly patients with moderate-to-severe sleep disorders. Through a meta-analysis of relevant randomized controlled trials (RCTs), it aims to determine the effectiveness of Tai Chi exercise in improving sleep quality in elderly patients with moderate-to-severe sleep disorders, as well as to compare its effects with those of traditional treatments; to analyze the safety of Tai Chi exercise for this patient population and assess its feasibility as a non-pharmacological therapy; and to fill the research gaps and provide more comprehensive and systematic evidence support. This study provides a practical approach to reducing the risk of medication side effects in older adults with sleep disorders and offers a potentially effective non-pharmacological treatment option, especially for those who are unable or unwilling to use medication. Tai chi exercise may not only improve sleep, but also improve coordination, muscle strength, balance, and reduce stress and anxiety in older adults. It also helps older adults socialize and enhances their social connections and emotional support. This study suggests that community centers or activity centers for the elderly can organize tai chi classes to promote the participation of older adults, and can be used as a scientific exercise rehabilitation tool in clinical treatment, incorporating tai chi practice into daily life, such as tai chi practice at a fixed time every day or every week, which not only helps to improve the sleep disorders of older adults, but also improves their overall quality of life.

2 July 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
JHJun Hu
Jun Hu
HLhaojie Li
haojie Li
Objective: Nasopharyngeal carcinoma (NPC) is a malignant tumor with significant disease burden. Currently, radiotherapy-based multimodal therapy remains the primary treatment strategy for NPC, yet consensus on the relative efficacy of induction chemotherapy, targeted therapy, and radiotherapy remains elusive. This study aims to systematically compare the relative efficacy of induction chemotherapy, targeted therapy, and radiotherapy on overall survival and treatment response using network meta-analysis, thereby providing evidence-based guidance for clinical decision-making. Methods: Following the PRISMA-NMA and Cochrane Manual guidelines, we systematically searched six databases (PubMed, Embase, Web of Science, Cochrane Library, EBSCO, and CNKI) for relevant randomized controlled trials (RCTs) published between January 1998 and June 2025. Two researchers independently conducted literature screening, data extraction, and risk of bias assessment. A total of 12 randomized controlled trials were ultimately included. Traditional meta-analysis and heterogeneity assessment were performed using RevMan 5.3 software. A network meta-analysis was conducted using STATA 17.0 software (Stata Corp LLC, College Station, TX, USA) based on a frequency framework, with interventions ranked by cumulative ranked probability area under the curve (SUCRA). Publication bias was evaluated using a corrected funnel plot. Results: Network meta-analysis showed that while TD ranked first in the probability of being the best treatment for OS (SUCRA = 98.1%), only IC demonstrated a statistically significant survival benefit compared to the control group (HR = 0.37, 95% CI: 0.02, 0.71). Regarding PFS, TD ranked first (SUCRA = 82.2%, HR = -0.68, 95% CI: -2.59, 1.23), although no intervention demonstrated a statistically significant benefit compared to the control group. In terms of ORR, IC had the highest probability (SUCRA = 71.6%, OR = 0.24, 95% CI: -2.18, 2.66), with no statistically significant differences among the interventions. Regarding CRR, TD showed the greatest advantage (SUCRA = 98.0%, OR = 0.26, 95% CI: 0.12, 0.58). Conclusion: The network meta-analysis results indicate that induction chemotherapy offers the greatest advantage in improving overall survival for nasopharyngeal carcinoma patients, while targeted drugs perform best in reducing cumulative recurrence risk. No statistically significant differences were observed among the three interventions for progression-free survival or objective response rate. Radiotherapy alone did not demonstrate significant benefit across any outcome measures. This study provides important evidence-based support for individualized treatment decisions in nasopharyngeal carcinoma. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/ , identifier CRD420251178558.